Maze Therapeutics, Inc. Common Stock (MAZE)
Who owns Maze Therapeutics, Inc. Common Stock (MAZE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.2% of the shares are freely tradable; institutional investors hold 95.6%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8.25 | 4,567,274 | +0.0 | 03/31/2026 |
| TRV GP IV, LLC | 8.08 | 4,473,958 | +0.0 | 03/31/2026 |
| ARCH VENTURE CORP | 7.44 | 4,120,053 | +0.0 | 03/31/2026 |
| Deep Track Capital, LP | 6.28 | 3,477,562 | -18.1 | 03/31/2026 |
| HHG PLC | 5.17 | 2,858,876 | -9.0 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 4.96 | 2,744,399 | +0.0 | 03/31/2026 |
| BlackRock Inc | 4.64 | 2,570,425 | +12.4 | 03/31/2026 |
| Vanguard Group Inc | 3.07 | 1,697,015 | +27.1 | 12/31/2025 |
| VR Adviser, LLC | 2.89 | 1,602,034 | +3.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.59 | 1,435,656 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Dandekar Atul | CSBO | Sell | 400 | 27.89 | 11,156 |
| 29. Jul 2026 | Dandekar Atul | CSBO | Sell | 7,100 | 27.31 | 193,875 |
| 29. Jul 2026 | Dandekar Atul | CSBO | Other | 7,500 | 10.42 | 78,150 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.